SPDR SER TR - S&P PHARMAC (XPH)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / S&P PHARMAC
Shares, excl. options Q3 2024
2.22M
Holdings value Q3 2024
$98.3M
Value change Q3 2024
-$21.7M
Grand Portfolio weight change Q3 2024
0%
Number of holders
70
Number of buys Q3 2024
24
Number of sells Q3 2024
-33
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 2.22M $98.3M -$21.7M $44.36 70
2024 Q2 2.65M $105M -$612K $39.78 72
2024 Q1 2.66M $115M -$11.1M $43.13 73
2023 Q4 2.92M $122M +$15.8M $41.62 70
2023 Q3 2.47M $98.3M -$16.9M $39.75 62
2023 Q2 2.84M $117M +$32M $40.99 57
2023 Q1 2.06M $84.5M -$23.6M $41.01 59
2022 Q4 2.64M $108M -$6.75M $40.95 69
2022 Q3 2.77M $111M +$9.89M $40.16 62
2022 Q2 2.52M $105M +$19M $42.00 68
2022 Q1 2.05M $92.7M -$12M $45.27 67
2021 Q4 2.3M $106M +$14.6M $46.15 74
2021 Q3 2.13M $101M -$2.21M $47.43 76
2021 Q2 2.17M $112M -$23.4M $51.76 78
2021 Q1 2.52M $127M -$10.7M $50.35 80
2020 Q4 2.72M $142M +$16.3M $52.06 78
2020 Q3 2.43M $105M -$12.4M $43.48 71
2020 Q2 2.72M $117M -$13.3M $42.98 70
2020 Q1 3.04M $110M -$50.1M $36.07 64
2019 Q4 4.9M $224M -$75.6M $45.67 75
2019 Q3 5.73M $204M +$64.2M $35.59 57
2019 Q2 3.88M $154M -$22.7M $39.83 58
2019 Q1 4.44M $185M +$33.2M $41.58 79
2018 Q4 3.86M $141M -$21.8M $36.62 70
2018 Q3 4.21M $204M +$32.5M $48.56 81
2018 Q2 3.59M $154M -$32.9M $43.01 67
2018 Q1 4.35M $182M +$53.7M $41.87 71
2017 Q4 2.98M $130M -$50.8M $43.50 81
2017 Q3 4.05M $172M +$1.76M $42.54 75
2017 Q2 4M $172M -$4.98M $43.03 76
2017 Q1 4.12M $172M +$14.3M $41.83 75
2016 Q4 3.8M $149M -$693K $39.09 75
2016 Q3 3.78M $167M +$3.1M $44.19 66
2016 Q2 3.72M $156M -$114M $41.79 58
2016 Q1 6.45M $259M +$46.3M $40.24 69
2015 Q4 5.29M $271M -$17.3M $51.20 74
2015 Q3 5.56M $261M +$116M $46.92 76
2015 Q2 2.81M $350M +$3.39M $124.70 82
2015 Q1 2.78M $343M -$7.09M $123.52 76
2014 Q4 2.86M $308M +$18.3M $107.96 76
2014 Q3 2.7M $286M -$52.7M $106.01 73
2014 Q2 3.2M $332M +$17.7M $103.80 67
2014 Q1 3.05M $286M +$10.2M $93.61 70